Skip to main content

Jim Cramer on the Social, Market Impact of COVID Booster Shots

Publish date:
Video Rating:
Video Duration:

Amid fierce public debate, a Food and Drugs Administration advisory committee is meeting to discuss the need for booster shots for members of the public over the age of 16.

The Vaccines and Related Biological Products Advisory Committee to the FDA will consider data submitted by Pfizer  (PFE) - Get Pfizer Inc. Report and Moderna  (MRNA) - Get Moderna, Inc. Report and will submit its recommendation. 

A vote among committee members is expected Friday afternoon. The FDA is not required to follow the recommendation, but often does so. 

Jim Cramer critiqued the FDA and CDC and explained the social and market impacts of booster shots in the video above. 

Recap TheStreet Live: Everything Jim Cramer Is Watching 9/17/21

Hear what Jim Cramer is only telling members of his Action Alerts PLUS investing club in Friday's Daily Rundown. 

Related Videos